Brian O Mahony/X
Nov 4, 2025, 09:17
HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
Brian O Mahony, CEO of Irish Haemophilia Society, Former President of WFH and EHC, posted on X.
” The first of our HaemophiliaIRL series of 6 clinical webinars has just started.
This evenings topic: New Therapeutic Possibilities for von Willebrand Disease.
Speaker is Prof. David Lillicrap from Canada. All who registered will recieve a specific e -zine and link to recording.”
Stay updated with Hemostasis Today.
-
Jul 10, 2026, 10:58Yara Alyahyawi: Advancing Epigenetic Therapy for Hemophilia B
-
Jul 10, 2026, 10:23Stephen Brown: Help Us Shape The Future of Hemophilia A Care
-
Jul 10, 2026, 09:57Katherine Rozycki: The Future of Haematology Through Education
-
Jul 10, 2026, 09:42Biljana Andrić: The Best Transfusion Is Often The One That Can Be Avoided
-
Jul 10, 2026, 09:27Farnaz Poorhasan: FFP is More Than Just Frozen Blood Components
-
Jul 10, 2026, 02:32Nina Laue: Looking Forward to Connecting and Collaborating at ISTH 2026
-
Jul 10, 2026, 02:19Anita Singla: Thalassemia Screening in Pregnancy Has a Lifelong Impact
-
Jul 10, 2026, 02:07Ruman Bashir: Immune Thrombocytopenia in Pregnancy
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation